Eupraxia Pharmaceuticals Inc opened trading today at $3.63 and closed at $3.70. Intraday prices ranged from $3.63 to $3.71.

Share prices advanced 0.27 percent from the previous day's close of $3.69.

Today across North America, the TSX Composite closed tsx_percentage_change% at 21807.37, the S&P 500 closed sp_500_percentage_change% at 5011.12, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37775.38 and the Nasdaq Composite closed nasdaq_percentage_change% at 15601.50.

Eupraxia Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker EPRX.

Trading volume was 10,100 on 27 total trades, while having an average volume of 77,301 over the last 5-days.

The TSX market on the whole today saw 2,775 price advancers against 2,424 declines and 120 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $9.10 (July 05,2023) and low as $3.44 (April 18,2024). Moreover, in the last 52 weeks, Eupraxia Pharmaceuticals Inc's shares have shrunken -32.23%, while this year, they have dipped -31.10%.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $131.45 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.17.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Currently, Eupraxia Pharmaceuticals Inc's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..